Our Roots
Born from the engineering precision of flight simulators and F-16 control systems, Symphony Robotics transforms aerospace technology into surgical innovation. Its AI-powered micro-robotic arm brings the same mastery of control and accuracy into the MRI suite. Through a single five-millimeter entry, Symphony enables neurosurgeons to navigate complex brain pathologies with unprecedented precision.
Imagine a micro-robot with the maneuverability of an F-16 — smoothly curving, pivoting, and steering through the brain with delicate precision, armed with a laser at its tip. This is what happens when a decade of breakthrough research led by nationally recognized researchers at Case Western Reserve University, Symphony Robotics’ AI-driven micro-robotic platform, and our partnership with the market leader in laser ablation (LITT) all come together: unprecedented access, accuracy, and control inside complex brain pathologies. It’s engineered hope — designed to reach regions of the brain that were once surgically unreachable.
Mordechai “Moty“ Avisar
Founder & CEO of Symphony Robotics
Monteris
“This partnership underscores our mission to redefine what is possible in brain surgery,” said Mordechai (Moty) Avisar, founder and chief executive officer of Symphony Robotics. “By integrating AI, micro-robotics, and real-time imaging, we are transforming the entire approach to treating brain disorders, not merely adding new surgical tools…”
Mass Device
Mordechai (Moty) Avisar, founder and CEO of Symphony Robotics, says the partnership underscores the company’s mission to “redefine what is possible in brain surgery.”
Source: https://www.massdevice.com/monteris-symphony-ai-microrobots-brain-ablation/
CW Austin
"Symphony Robotics is built on a foundation of rigorous research and a robust intellectual property portfolio, supported by grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and exclusively licensed from Case Western Reserve University," said Mordechai (Moty) Avisar, Founder and CEO of Symphony Robotics.
Crain’s Cleveland Business
“Avisar, who had built high‑tech flight simulators for the Israeli Air Force, bumped into Dr. Warren Selman … the idea took off.”
Source: https://www.crainscleveland.com/article/20140504/SUB1/305049959/surgeons-
Healthcare in Europe
“Products … are the brainchild of a career Israeli Air Force flight simulation designer, Moty Avisar”
Source: https://healthcare-in-europe.com/en/news/virtual-assistance-during-
EDN
“We are extremely excited to expand our offerings beyond planning and rehearsing surgeries outside the OR” — Moty Avisar
Source: https://www.edn.com/surgical-theaters-surgical-navigation-advanced-platform-
OurCrowd / Yahoo Finance
“We are very excited to grow our global presence ... Increasing numbers of surgeons across the world will be able to use this novel technology to advance the way they perform surgeries.” — Moty Avisar
Source: https://blog.ourcrowd.com/surgical-theater-received-approval-to-market-the-
surgical-navigation-advanced-platform-snap-and-surgical-planner-srp-systems-from-the-
From Flight Deck to Brain Surgery: An Interview with Moty Avisar
Few journeys bridge the gap between defending the skies and healing the human brain. Moty Avisar, former engineering officer in the Israeli Air Force and now Founder & CEO of Symphony Robotics, embodies that rare intersection of precision, vision, and courage. In this exclusive interview, Moty reflects on how the same spirit that powered his work on F-16 flight and weapon systems now fuels his passion for developing a micro-robot that ‘flies’ through the brain — redefining what’s possible in neurosurgery.
-
A: I’ve always been fascinated by systems that merge human intuition with engineering precision. The Air Force gave me a front-row seat to that balance — designing, testing, and flying systems that had to perform flawlessly under immense pressure. It was an environment where precision wasn’t optional — it was life or death.
-
A: When you design avionics or flight control systems, you learn humility before complexity. Every signal, every line of code, every sensor matters. That mindset carried into everything I’ve done since. I realized that in both aviation and medicine, precision is sacred — it’s the foundation of trust.
-
A: It was actually a natural evolution. The same situational awareness we developed for fighter pilots — understanding complex 3D environments, predicting trajectories, and preventing errors — applies beautifully to the operating room. I wanted to take that discipline of flight and bring it to healing.
-
A: The Symphony micro-robot is designed to move through the brain with the same grace and control as an F-16 through the sky. It’s flexible, precise, and guided in real time by MRI — our version of a radar or flight control system. Instead of firing missiles, it delivers therapies: heat, light, or drugs — directly into the core of a tumor.
-
A: It’s about closing the circle. I spent years helping pilots master the skies, and now I’m helping surgeons navigate the most intricate space imaginable — the human brain. It’s still flight, just in a different dimension.
-
A: Traditional systems are rigid — they follow a straight path. The Symphony robot follows nature’s curves. It can reach multiple targets from a single entry, adapt its trajectory mid-flight, and coordinate energy and agents in one synchronized approach. It’s precision reborn.
-
A: The hardest challenge is staying humble before the complexity of the human body. We’re building machines that must be as intuitive as a surgeon’s hand and as trustworthy as a pilot’s instrument panel. That requires deep collaboration between engineers, clinicians, and visionaries.
-
A: In the Air Force, you learn to protect. In medicine, you learn to heal. They’re both acts of service. What connects them is care — care for the mission, for the people, and for the future. That’s what keeps me grounded.
-
A: It’s the belief that healing isn’t just one instrument — it’s harmony. Imaging, robotics, AI, therapy — all working together through a single entry point. That’s the symphony we’re conducting, one 5mm entry at a time.
-
A: My dream is to make a meaningful impact in diseases that today are considered losing battles — especially Glioblastoma (GBM), and maybe in the future even pancreatic cancer. These are among the toughest frontiers in medicine, but I believe that with precision robotics, imaging, and AI working in harmony, we can begin to change their trajectories. If we can turn even one of these battles into a story of survival and hope, then every hour spent designing, testing, and dreaming will have been worth it.